Cancer as a dysregulated epigenome allowing cellular growth advantage at the expense of the host
about
Stress-triggered atavistic reprogramming (STAR) addiction: driving force behind head and neck cancer?Export of microRNAs: A Bridge between Breast Carcinoma and Their Neighboring CellsRegulation of Differentiation by Calcium-Sensing Receptor in Normal and Tumoral Developing Nervous SystemEpigenetic modulators, modifiers and mediators in cancer aetiology and progressionChallenges of deciphering gastric cancer heterogeneityBioinformatics for precision medicine in oncology: principles and application to the SHIVA clinical trialEndogenous retroviral promoter exaptation in human cancerRecent Advances in Immunotherapy in Metastatic NSCLCAir pollution, epigenetics, and asthmaThe Emergence of Pan-Cancer CIMP and Its Elusive InterpretationPD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinationsEpigenetics in Cancer: A Hematological PerspectiveEpigenetic determinants of metastasisCorrelation of an epigenetic mitotic clock with cancer riskGenome-wide mapping of histone H3K9me2 in acute myeloid leukemia reveals large chromosomal domains associated with massive gene silencing and sites of genome instability.ChromoHub V2: cancer genomics.Validation study of genes with hypermethylated promoter regions associated with prostate cancer recurrence.H3K4me1 marks DNA regions hypomethylated during aging in human stem and differentiated cellsGenome-wide methylation study on depression: differential methylation and variable methylation in monozygotic twinsPhenotype prediction based on genome-wide DNA methylation data.Modelling mutational landscapes of human cancers in vitro.Stemness in Cancer: Stem Cells, Cancer Stem Cells, and Their Microenvironment.Genome-wide DNA methylation analysis identifies MEGF10 as a novel epigenetically repressed candidate tumor suppressor gene in neuroblastomaA knowledge-based framework for the discovery of cancer-predisposing variants using large-scale sequencing breast cancer dataA promoter-proximal transcript targeted by genetic polymorphism controls E-cadherin silencing in human cancers.Epigenetic stochasticity, nuclear structure and cancer: the implications for medicine.Aiolos promotes anchorage independence by silencing p66Shc transcription in cancer cells.Genetic Mutations and Epigenetic Modifications: Driving Cancer and Informing Precision Medicine.Frequent mutations in chromatin-remodelling genes in pulmonary carcinoids.Evolution of DNA methylation is linked to genetic aberrations in chronic lymphocytic leukemiaCompeting views on cancer.PKM2: the thread linking energy metabolism reprogramming with epigenetics in cancerDistinct isoform of FABP7 revealed by screening for retroelement-activated genes in diffuse large B-cell lymphoma.A developmental genetic analysis of the lysine demethylase KDM2 mutations in Drosophila melanogaster.Genotranscriptomic meta-analysis of the Polycomb gene CBX2 in human cancers: initial evidence of an oncogenic role.Aging genomes: a necessary evil in the logic of life.DNA methylation in cancer: three decades of discovery.Chemical profiling of the genome with anti-cancer drugs defines target specificities.DNA methylation reprogramming in cancer: does it act by re-configuring the binding landscape of Polycomb repressive complexes?Epigenetic signatures of alcohol abuse and hepatitis infection during human hepatocarcinogenesis.
P2860
Q26739748-24B59BAD-BDCC-4A24-9243-25CD89C1A1FEQ26744487-2644B009-4D8A-4CB9-9DA9-29D07D215AA5Q26744719-DD49F698-6308-4484-A45A-F70FE8FC5439Q26766149-DA02B528-B258-4F7F-AAE5-AFB0B88576F2Q26784448-31572DFB-288F-4AEF-95AB-5B577B29DA73Q27015838-5ED2CE4A-845B-41E5-95BB-8C3EFD0E20DCQ28067477-3127C7C5-6A29-4A82-B3AC-4E2E66418916Q28069323-446EB088-A01E-460E-87C5-2E2CE3D937A3Q28072114-8459A061-2A22-4F5A-A20D-494FB4981FD8Q28075374-ED8DC0B8-C2F5-4B3A-98EE-74711C5EB7F0Q28075712-2032FD91-7EC5-4E1B-A725-FA472DBB5A07Q28077082-E7AB45E8-1D51-432E-B4AE-C1BB38F4ADECQ28079377-0F698B33-8E7F-47DF-B911-E110683C0D2CQ28390569-727FF11E-65D9-407E-9ECA-C593318AE21BQ30252934-326C6E89-8477-4D93-93FA-9D78BEDEEE97Q30486546-D80C9C28-BE8F-4B1C-9018-7A2E68E5CB75Q30582750-FCEB5A9C-8402-48BB-B618-6AC356EABA69Q30619629-40A687BF-56A5-4415-BC5E-B4BEFBF4EE04Q30654005-C3958C8C-4247-49DC-89CA-8AE12C5E9F45Q30831512-06DEAFAF-9A5D-4502-8B4C-C2BEF3A8CAC2Q30836093-87C9A297-7EB2-439B-B7CE-6DE6EEA9C96CQ33572252-57A36F6F-50AB-46C1-BEA9-8BA5A5EA3AB8Q33578303-1A4CA1F0-1C89-4DF7-8642-1FFBFA8159E8Q33750026-50BC34F3-8B83-4330-9F19-36B9123E7B9CQ33766602-09B33DF3-4D8C-45E2-94A1-5655F09361F7Q33784706-1BE0344E-868C-4DFC-92FE-946610E21650Q33806421-770A8CF8-F388-4500-BB70-ADD8473AB858Q33823065-6B90B8E8-D913-4F69-AEB1-7134FDD3F70EQ34045543-A265B8B9-D561-4761-B5EC-D55BA6C00BCAQ34052080-C992C650-E3EB-4487-B38D-84727CD1F6D6Q34060169-F1ED9048-30EE-4BCE-96A5-BF4D890168D2Q34072206-B5D5D1B0-657E-4845-94D9-58C270DA67F8Q34120178-29AE3BAA-63D9-4C52-AAEC-9407D20D6B6EQ34254480-F4CA6655-3A75-4BCD-A9B0-1E05CB19EE3FQ34354646-BB63894E-C386-476E-8BBC-65B405FDDE74Q34400145-C7593BFD-A559-4100-963B-7A0A4DFD66F8Q34429391-AC4F2FAE-C4F9-4FC3-BD33-08CD9F0D792CQ34475915-E5876F22-4DB6-4D46-A1C3-F5364FD53E87Q34477447-6D4E1D6E-1B1D-4A90-B12C-CDB34203B4CEQ34619389-BBDBD67F-BD01-43A7-A16A-A120D9E9BF2D
P2860
Cancer as a dysregulated epigenome allowing cellular growth advantage at the expense of the host
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Cancer as a dysregulated epige ...... age at the expense of the host
@ast
Cancer as a dysregulated epige ...... age at the expense of the host
@en
type
label
Cancer as a dysregulated epige ...... age at the expense of the host
@ast
Cancer as a dysregulated epige ...... age at the expense of the host
@en
prefLabel
Cancer as a dysregulated epige ...... age at the expense of the host
@ast
Cancer as a dysregulated epige ...... age at the expense of the host
@en
P2860
P356
P1476
Cancer as a dysregulated epige ...... age at the expense of the host
@en
P2093
Andrew P Feinberg
Winston Timp
P2860
P2888
P304
P356
10.1038/NRC3486
P407
P577
2013-06-13T00:00:00Z